Oesophageal Cancer Trial, Recruiting NCT04519905 Sponsor: Fudan University Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Oesophageal Cancer Trial, Recruiting

NCT04519905
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Participants must be at least 76 years old
  • You must have been diagnosed with a specific type of esophageal cancer (squamous cell carcinoma), confirmed by a tissue test (pathology)
  • Your cancer must be at a locally advanced stage, as defined by specific staging criteria (confirm with trial site)
  • You must not have received any radiotherapy, chemotherapy, or other cancer treatments before joining
  • You must be willing to use effective contraception to prevent pregnancy during the trial
  • Your heart, lungs, kidneys, liver, and blood cell production must all be working well enough, with no serious problems
  • You must not have a weakened immune system
  • You must be in good enough general health to carry out daily activities with no more than minor limitations (this is measured by a standard scale called ECOG 0–1)
  • You are expected to live for more than 3 months

Who may not be able to join:

  • People whose cancer cannot be safely treated with the full required radiation dose planned for this trial (confirm with trial site)
  • People who have a hole or tear in the esophagus, or who have been vomiting blood
  • People who have previously had radiotherapy or chemotherapy for esophageal cancer
  • People who have had surgery within 28 days before the trial start date
  • People who have had another type of cancer in the past, unless it was a common type of skin cancer or early-stage cervical cancer and they have been cancer-free for at least 3 years
  • People who are currently taking part in another clinical trial or have done so within the last 30 days
  • Women who are pregnant or breastfeeding, or anyone who is able to have children and is not using contraception
  • People with a history of drug addiction or alcoholism
  • People living with AIDS
  • People with uncontrolled seizures or serious psychiatric (mental health) conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kuaile Zhao, doctor, Fudan University

Phone: 18017312534

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 January 2020
Est. completion
1 December 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

overall survival difference of definitive radiotherapy and chemoradiotherapy groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov